Efficacy and Safety Evaluation of Tarlatamab in Advanced Extrapulmonary Neuroendocrine Carcinoma Patients
Abroad (travel likely)RecruitingPHASE2
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Neuroendocrine Carcinomas (NEC) · Neuroendocrine Carcinoma of Pancreas · Neuroendocrine Carcinoma of Prostate
Locations
- Asan Medical Center, Seoul, South Korea
- Samsung Medical Center, Seoul, South Korea
- Seoul National University Hospital, Seoul, South Korea
- Yonsei Severance Hospital, Seoul, South Korea